Technology is transforming healthcare. Not only are genomic treatments for several diseases becoming more affordable, but also digitalized healthcare is growing fast. VanEck’s Genomics and Healthcare Innovators UCITS ETF invests in the businesses pioneering ways to treat disease and connect with patients.
- Invest in genomics companies developing new ways to treat health problems such as genetic conditions, cancer and conditions related to ageing
- Gain exposure to digital health services providers – delivering easy access to doctors, physiotherapists, nurses and pharmacists
- Pure-play exposure to companies earning at least half their revenues from genomics- or e-healthcare-related industries
- Invest in an ETF that screens out companies that violate social norms, derive revenues from controversial weapons, or participate in fossil fuel sectors, nuclear power, civilian firearms or tobacco
Risk: You may lose money up to the total loss of your investment due to the Main Risk Factors such as Equity Market Risk and Industry Concentration Risk described below in the KID and in the sales prospectus. Evolving of the market not guaranteed.
MVIS® Global Future Healthcare ESG Index (MVFHCTR)